Corbus Pharmaceuticals Holdings, Inc. Line of Credit Facility, Increase (Decrease), Net
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Line of Credit Facility, Increase (Decrease), Net of $36.38 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-12.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet · last filed 2016-08-12
- Corbus Pharmaceuticals Holdings, Inc. line of credit facility, increase (decrease), net for the quarter ending 2016-06-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. line of credit facility, increase (decrease), net for the quarter ending 2016-03-31 was $36.38K.
- Corbus Pharmaceuticals Holdings, Inc. line of credit facility, increase (decrease), net for the quarter ending 2015-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. line of credit facility, increase (decrease), net for fiscal 2015 was $36.38K.
| Period end | Line of Credit Facility, Increase (Decrease), Net 3 month | Line of Credit Facility, Increase (Decrease), Net 6 month | Line of Credit Facility, Increase (Decrease), Net 9 month | Line of Credit Facility, Increase (Decrease), Net 12 month |
|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $36.38K 10-Q · filed 2016-08-12 | $36.38K derived: sum of 3 quarters · filed 2016-08-12 | |
| 2016-03-31 | $36.38K 10-Q · filed 2016-05-13 | $36.38K derived: sum of 2 quarters · filed 2016-05-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $36.38K 10-K · filed 2016-03-28 | ||
| 2015-09-30 | $36.38K 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |